Entia Biosciences, Inc.
company.status.inactiveCIK 1408299fmd_1ZTJNE63MXE3C5G47APDSWZX5PManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2010 to Dec 31, 2016, 27 periods
| Line item | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 |
|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Research and development | – | 0 | 0 | 0 | 0 | 0 | 0 |
| Total operating expenses | 1 | 2 | 1 | 3 | 2 | 2 | 1 |
| Operating income | (1) | (1) | (1) | (3) | (2) | (2) | (1) |
| Interest expense | – | – | – | 0 | 0 | 0 | 0 |
| Interest and investment income | (0) | 0 | 0 | 0 | 0 | – | – |
| Other non-operating income (expense) | 0 | (0) | – | 0 | 0 | (0) | (0) |
| Income before taxes | (1) | (2) | – | – | – | – | – |
| Income tax expense | 0 | 0 | – | 0 | 0 | 0 | 0 |
| Net income from continuing operations | (1) | (2) | – | – | – | – | – |
| Net income | (1) | (2) | (1) | (3) | (2) | (2) | (1) |
| Net income to common shareholders | – | (2) | (1) | (3) | (2) | (2) | (1) |